4acr Citations

Crystal structure of N-glycosylated human glypican-1 core protein: structure of two loops evolutionarily conserved in vertebrate glypican-1.

J Biol Chem 287 14040-51 (2012)
Cited: 41 times
EuropePMC logo PMID: 22351761

Abstract

Glypicans are a family of cell-surface proteoglycans that regulate Wnt, hedgehog, bone morphogenetic protein, and fibroblast growth factor signaling. Loss-of-function mutations in glypican core proteins and in glycosaminoglycan-synthesizing enzymes have revealed that glypican core proteins and their glycosaminoglycan chains are important in shaping animal development. Glypican core proteins consist of a stable α-helical domain containing 14 conserved Cys residues followed by a glycosaminoglycan attachment domain that becomes exclusively substituted with heparan sulfate (HS) and presumably adopts a random coil conformation. Removal of the α-helical domain results in almost exclusive addition of the glycosaminoglycan chondroitin sulfate, suggesting that factors in the α-helical domain promote assembly of HS. Glypican-1 is involved in brain development and is one of six members of the vertebrate family of glypicans. We expressed and crystallized N-glycosylated human glypican-1 lacking HS and N-glycosylated glypican-1 lacking the HS attachment domain. The crystal structure of glypican-1 was solved using crystals of selenomethionine-labeled glypican-1 core protein lacking the HS domain. No additional electron density was observed for crystals of glypican-1 containing the HS attachment domain, and CD spectra of the two protein species were highly similar. The crystal structure of N-glycosylated human glypican-1 core protein at 2.5 Å, the first crystal structure of a vertebrate glypican, reveals the complete disulfide bond arrangement of the conserved Cys residues, and it also extends the structural knowledge of glypicans for one α-helix and two long loops. Importantly, the loops are evolutionarily conserved in vertebrate glypican-1, and one of them is involved in glycosaminoglycan class determination.

Reviews - 4acr mentioned but not cited (1)

  1. Role of glypican-1 in regulating multiple cellular signaling pathways. Pan J, Ho M. Am J Physiol Cell Physiol 321 C846-C858 (2021)

Articles - 4acr mentioned but not cited (9)

  1. Crystal structure of N-glycosylated human glypican-1 core protein: structure of two loops evolutionarily conserved in vertebrate glypican-1. Svensson G, Awad W, Håkansson M, Mani K, Logan DT. J. Biol. Chem. 287 14040-14051 (2012)
  2. Cysteine-rich domains related to Frizzled receptors and Hedgehog-interacting proteins. Pei J, Grishin NV. Protein Sci. 21 1172-1184 (2012)
  3. A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope. Raman S, Buongervino SN, Lane MV, Zhelev DV, Zhu Z, Cui H, Martinez B, Martinez D, Wang Y, Upton K, Patel K, Rathi KS, Navia CT, Harmon DB, Li Y, Pawel B, Dimitrov DS, Maris JM, Julien JP, Bosse KR. Cell Rep Med 2 100344 (2021)
  4. Improvements in the order, isotropy and electron density of glypican-1 crystals by controlled dehydration. Awad W, Svensson Birkedal G, Thunnissen MM, Mani K, Logan DT. Acta Crystallogr. D Biol. Crystallogr. 69 2524-2533 (2013)
  5. Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance. Enkavi G, Javanainen M, Kulig W, Róg T, Vattulainen I. Chem. Rev. 119 5607-5774 (2019)
  6. Systems genetic analysis of hippocampal neuroanatomy and spatial learning in mice. Delprato A, Bonheur B, Algéo MP, Rosay P, Lu L, Williams RW, Crusio WE. Genes Brain Behav. 14 591-606 (2015)
  7. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  8. Structural Aspects of N-Glycosylations and the C-terminal Region in Human Glypican-1. Awad W, Adamczyk B, Örnros J, Karlsson NG, Mani K, Logan DT. J. Biol. Chem. 290 22991-23008 (2015)
  9. The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer. Li N, Quan A, Li D, Pan J, Ren H, Hoeltzel G, de Val N, Ashworth D, Ni W, Zhou J, Mackay S, Hewitt SM, Cachau R, Ho M. Nat Commun 14 1986 (2023)


Reviews citing this publication (11)

  1. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Iozzo RV, Schaefer L. Matrix Biol. 42 11-55 (2015)
  2. Insights into the key roles of proteoglycans in breast cancer biology and translational medicine. Theocharis AD, Skandalis SS, Neill T, Multhaupt HA, Hubo M, Frey H, Gopal S, Gomes A, Afratis N, Lim HC, Couchman JR, Filmus J, Sanderson RD, Schaefer L, Iozzo RV, Karamanos NK. Biochim. Biophys. Acta 1855 276-300 (2015)
  3. Proteoglycans and neuronal migration in the cerebral cortex during development and disease. Maeda N. Front Neurosci 9 98 (2015)
  4. Glypican-3 antibodies: a new therapeutic target for liver cancer. Feng M, Ho M. FEBS Lett. 588 377-382 (2014)
  5. Boning up on glypicans--opportunities for new insights into bone biology. Dwivedi PP, Lam N, Powell BC. Cell Biochem. Funct. 31 91-114 (2013)
  6. Role of Matricellular Proteins in Disorders of the Central Nervous System. Jayakumar AR, Apeksha A, Norenberg MD. Neurochem. Res. 42 858-875 (2017)
  7. Extracellular regulation of type IIa receptor protein tyrosine phosphatases: mechanistic insights from structural analyses. Coles CH, Jones EY, Aricescu AR. Semin. Cell Dev. Biol. 37 98-107 (2015)
  8. Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3. Li N, Spetz MR, Li D, Ho M. Pharmacol Ther 223 107892 (2021)
  9. Glypicans as Cancer Therapeutic Targets. Li N, Gao W, Zhang YF, Ho M. Trends Cancer 4 741-754 (2018)
  10. The function of glypicans in the mammalian embryo. Filmus J. Am J Physiol Cell Physiol 322 C694-C698 (2022)
  11. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma. Busato D, Mossenta M, Dal Bo M, Macor P, Toffoli G. Int J Mol Sci 23 10279 (2022)

Articles citing this publication (20)

  1. Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy. Gao W, Kim H, Feng M, Phung Y, Xavier CP, Rubin JS, Ho M. Hepatology 60 576-587 (2014)
  2. Structure and function of the Smoothened extracellular domain in vertebrate Hedgehog signaling. Nachtergaele S, Whalen DM, Mydock LK, Zhao Z, Malinauskas T, Krishnan K, Ingham PW, Covey DF, Siebold C, Rohatgi R. Elife 2 e01340 (2013)
  3. Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Feng M, Gao W, Wang R, Chen W, Man YG, Figg WD, Wang XW, Dimitrov DS, Ho M. Proc. Natl. Acad. Sci. U.S.A. 110 E1083-91 (2013)
  4. ECOD: an evolutionary classification of protein domains. Cheng H, Schaeffer RD, Liao Y, Kinch LN, Pei J, Shi S, Kim BH, Grishin NV. PLoS Comput. Biol. 10 e1003926 (2014)
  5. Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis. Wen J, Xiao J, Rahdar M, Choudhury BP, Cui J, Taylor GS, Esko JD, Dixon JE. Proc. Natl. Acad. Sci. U.S.A. 111 15723-15728 (2014)
  6. Two functional domains in C. elegans glypican LON-2 can independently inhibit BMP-like signaling. Taneja-Bageshwar S, Gumienny TL. Dev. Biol. 371 66-76 (2012)
  7. Non-conserved, S-nitrosylated cysteines in glypican-1 react with N-unsubstituted glucosamines in heparan sulfate and catalyze deaminative cleavage. Cheng F, Svensson G, Fransson LÅ, Mani K. Glycobiology 22 1480-1486 (2012)
  8. Non-toxic amyloid beta formed in the presence of glypican-1 or its deaminatively generated heparan sulfate degradation products. Cheng F, Ruscher K, Fransson LÅ, Mani K. Glycobiology 23 1510-1519 (2013)
  9. Editorial Glycosaminoglycans and Proteoglycans. Pomin VH, Mulloy B. Pharmaceuticals (Basel) 11 (2018)
  10. Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization. Truong Q, Justiniano IO, Nocon AL, Soon JT, Wissmueller S, Campbell DH, Walsh BJ. J Cancer 7 1002-1009 (2016)
  11. Regulation of TGFβ superfamily signaling by two separable domains of glypican LON-2 in C. elegans. Taneja-Bageshwar S, Gumienny TL. Worm 2 e23843 (2013)
  12. Identification and expression analysis of zebrafish glypicans during embryonic development. Gupta M, Brand M. PLoS ONE 8 e80824 (2013)
  13. GPC3-Unc5 receptor complex structure and role in cell migration. Akkermans O, Delloye-Bourgeois C, Peregrina C, Carrasquero-Ordaz M, Kokolaki M, Berbeira-Santana M, Chavent M, Reynaud F, Raj R, Agirre J, Aksu M, White ES, Lowe E, Ben Amar D, Zaballa S, Huo J, Pakos I, McCubbin PTN, Comoletti D, Owens RJ, Robinson CV, Castellani V, Del Toro D, Seiradake E. Cell 185 3931-3949.e26 (2022)
  14. Structure, Dynamics, and Interactions of GPI-Anchored Human Glypican-1 with Heparan Sulfates in a Membrane. Dong C, Choi YK, Lee J, Zhang XF, Honerkamp-Smith A, Widmalm G, Lowe-Krentz LJ, Im W. Glycobiology 31 593-602 (2021)
  15. Anti-GPC3 single-chain scFv antibody acts as an agent for radio-immunoimaging in diagnosing hepatocellular carcinoma. Guan L, Wu W, Pang H, Duan D, Li S. Am J Transl Res 11 7422-7431 (2019)
  16. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior. Cheng F, Hansson VC, Georgolopoulos G, Mani K. Oncotarget 14 219-235 (2023)
  17. Hedgehog pathway modulation by glypican 3-conjugated heparan sulfate. Liu YC, Wierbowski BM, Salic A. J Cell Sci 135 jcs259297 (2022)
  18. Hypoxia induces NO-dependent release of heparan sulfate in fibroblasts from the Alzheimer mouse Tg2576 by activation of nitrite reduction. Cheng F, Bourseau-Guilmain E, Belting M, Fransson LÅ, Mani K. Glycobiology 26 623-634 (2016)
  19. Netrin-1: A Serum Marker Predicting Cognitive Impairment after Spinal Cord Injury. Meng Y, Sun S, Cao S, Shi B. Dis Markers 2022 1033197 (2022)
  20. Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth. Quach ND, Kaur SP, Eggert MW, Ingram L, Ghosh D, Sheth S, Nagy T, Dawson MR, Arnold RD, Cummings BS. Sci Rep 9 11478 (2019)